Why the Rhythm Biosciences (ASX:RHY) share price is racing 6% higher

This healthcare share is now up 1,000% over the last 12 months…

| More on:
four excited doctors with their hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Rhythm Biosciences Ltd (ASX: RHY) share price has been a strong performer on Thursday.

In afternoon trade, the early cancer detection-focused predictive diagnostics company's shares are up 6% to 90 cents.

This latest gain means the Rhythm Biosciences share price is now up over 1,000% during the last 12 months.

Why is the Rhythm Biosciences share price charging higher today?

The catalyst for the rise in the Rhythm Biosciences share price on Thursday has been the release of an update on its US expansion strategy.

According to the release, the company has established a wholly owned US domiciled entity, IchorDX, as part of its US market entry plan. Management notes that this will enable Rhythm to pursue its international expansion activities for ColoSTAT in one of its largest priority markets.

ColoSTAT is the company's lead product and intended to be a simple, affordable, minimally invasive and effective blood test for the early detection of bowel cancer.

The release highlights that the US market represents one of the largest diagnostic markets in the world, with a current addressable market of over 94 million people. It also sees scope for this number to grow in the short term by a further 21%. This follows the US Preventative Services Task Force's recommendation that the colorectal cancer screening age be reduced from 50 to 45 years of age.

In light of this, it isn't hard to see why the Rhythm Biosciences share price is on the rise again today.

Rhythm's CEO, Glenn Gilbert, commented: "The establishment of IchorDX, Inc., in the US demonstrates our commitment to accelerate our international expansion plans, offer additional optionality to our corporate structure and aim to create a global footprint for Rhythm's transformative cancer detection technology."

"The reality is that the global need for a simple and accurate mass screening blood test for colorectal cancer is growing. This first step to enter the US market moves Rhythm closer to meeting this need," he added.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »